Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 179

1.

IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma.

Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE.

Clin Cancer Res. 2015 May 1;21(9):2167-76. doi: 10.1158/1078-0432.CCR-14-1826.

PMID:
25934889
2.

Jumping translocations, a novel finding in chronic lymphocytic leukaemia.

Miller CR, Stephens D, Ruppert AS, Racke F, McFaddin A, Breidenbach H, Lin HJ, Waller K, Bannerman T, Jones JA, Woyach JA, Andritsos LA, Maddocks K, Zhao W, Lozanski G, Flynn JM, Grever M, Byrd JC, Heerema NA.

Br J Haematol. 2015 Apr 19. doi: 10.1111/bjh.13422. [Epub ahead of print]

PMID:
25891862
3.

Efficacy of Carboplatin Alone and in Combination with ABT888 in Intracranial Murine Models of BRCA-Mutated and BRCA-Wild-Type Triple-Negative Breast Cancer.

Karginova O, Siegel MB, Van Swearingen AE, Deal AM, Adamo B, Sambade MJ, Bazyar S, Nikolaishvili-Feinberg N, Bash R, O'Neal S, Sandison K, Parker JS, Santos C, Darr D, Zamboni W, Lee YZ, Miller CR, Anders CK.

Mol Cancer Ther. 2015 Apr;14(4):920-30. doi: 10.1158/1535-7163.MCT-14-0474.

PMID:
25824335
4.

Inference for one-step beneficial mutations using next generation sequencing.

Wojtowicz AJ, Miller CR, Joyce P.

Stat Appl Genet Mol Biol. 2015 Feb;14(1):65-81. doi: 10.1515/sagmb-2014-0030.

PMID:
25720101
5.

Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis.

Prabhu A, Sarcar B, Miller CR, Kim SH, Nakano I, Forsyth P, Chinnaiyan P.

Neuro Oncol. 2015 Feb 23. pii: nou369. [Epub ahead of print]

PMID:
25712957
6.

Tuberculosis contact investigation in low- and middle-income countries: standardized definitions and indicators.

Fair E, Miller CR, Ottmani SE, Fox GJ, Hopewell PC.

Int J Tuberc Lung Dis. 2015 Mar;19(3):269-72. doi: 10.5588/ijtld.14.0512.

PMID:
25686131
7.

Combining natural sequence variation with high throughput mutational data to reveal protein interaction sites.

Melamed D, Young DL, Miller CR, Fields S.

PLoS Genet. 2015 Feb 11;11(2):e1004918. doi: 10.1371/journal.pgen.1004918. eCollection 2015 Feb.

8.

Nanoscale assembly of lanthanum silica with dense and porous interfacial structures.

Ballinger B, Motuzas J, Miller CR, Smart S, Diniz da Costa JC.

Sci Rep. 2015 Feb 3;5:8210. doi: 10.1038/srep08210.

9.

Health worker perspectives on barriers to delivery of routine tuberculosis diagnostic evaluation services in Uganda: a qualitative study to guide clinic-based interventions.

Cattamanchi A, Miller CR, Tapley A, Haguma P, Ochom E, Ackerman S, Davis JL, Katamba A, Handley MA.

BMC Health Serv Res. 2015 Jan 22;15:10. doi: 10.1186/s12913-014-0668-0.

10.

Changing folding and binding stability in a viral coat protein: a comparison between substitutions accessible through mutation and those fixed by natural selection.

Miller CR, Lee KH, Wichman HA, Ytreberg FM.

PLoS One. 2014 Nov 18;9(11):e112988. doi: 10.1371/journal.pone.0112988. eCollection 2014.

11.

A novel role for otolaryngologists in the multidisciplinary Difficult Airway Response Team.

Hillel AT, Pandian V, Mark LJ, Clark J, Miller CR, Haut ER, Cover R, Berkow LC, Agrawal Y, Bhatti N.

Laryngoscope. 2015 Mar;125(3):640-4. doi: 10.1002/lary.24949. Epub 2014 Sep 24.

PMID:
25251732
12.

Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.

Galvao RP, Kasina A, McNeill RS, Harbin JE, Foreman O, Verhaak RG, Nishiyama A, Miller CR, Zong H.

Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):E4214-23. doi: 10.1073/pnas.1414389111. Epub 2014 Sep 22.

13.

Contemporary murine models in preclinical astrocytoma drug development.

McNeill RS, Vitucci M, Wu J, Miller CR.

Neuro Oncol. 2015 Jan;17(1):12-28. doi: 10.1093/neuonc/nou288. Epub 2014 Sep 21.

PMID:
25246428
14.

Effects of tumor microenvironment heterogeneity on nanoparticle disposition and efficacy in breast cancer tumor models.

Song G, Darr DB, Santos CM, Ross M, Valdivia A, Jordan JL, Midkiff BR, Cohen S, Nikolaishvili-Feinberg N, Miller CR, Tarrant TK, Rogers AB, Dudley AC, Perou CM, Zamboni WC.

Clin Cancer Res. 2014 Dec 1;20(23):6083-95. doi: 10.1158/1078-0432.CCR-14-0493. Epub 2014 Sep 17.

PMID:
25231403
15.

Modeling astrocytoma pathogenesis in vitro and in vivo using cortical astrocytes or neural stem cells from conditional, genetically engineered mice.

McNeill RS, Schmid RS, Bash RE, Vitucci M, White KK, Werneke AM, Constance BH, Huff B, Miller CR.

J Vis Exp. 2014 Aug 12;(90):e51763. doi: 10.3791/51763.

PMID:
25146643
16.

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK.

Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25.

PMID:
24613583
17.

Utilization of a standardized tracheostomy capping and decannulation protocol to improve patient safety.

Pandian V, Miller CR, Schiavi AJ, Yarmus L, Contractor A, Haut ER, Feller-Kopman DJ, Mirski MA, Morad AH, Carey JP, Hillel AT, Maragos CS, Bhatti NI.

Laryngoscope. 2014 Aug;124(8):1794-800. doi: 10.1002/lary.24625. Epub 2014 Apr 4.

PMID:
24473939
18.

ASC deficiency suppresses proliferation and prevents medulloblastoma incidence.

Knight ER, Patel EY, Flowers CA, Crowther AJ, Ting JP, Miller CR, Gershon TR, Deshmukh M.

Oncogene. 2015 Jan 15;34(3):394-402. doi: 10.1038/onc.2013.577. Epub 2014 Jan 27.

PMID:
24469054
19.

Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal.

Zhou B, Damrauer JS, Bailey ST, Hadzic T, Jeong Y, Clark K, Fan C, Murphy L, Lee CY, Troester MA, Miller CR, Jin J, Darr D, Perou CM, Levine RL, Diehn M, Kim WY.

J Clin Invest. 2014 Feb;124(2):553-63. doi: 10.1172/JCI69804. Epub 2014 Jan 2.

20.

MEK1/2 inhibitors in the treatment of gynecologic malignancies.

Miller CR, Oliver KE, Farley JH.

Gynecol Oncol. 2014 Apr;133(1):128-37. doi: 10.1016/j.ygyno.2014.01.008. Epub 2014 Jan 14. Review.

PMID:
24434059
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk